Two Yale Department of Pathology graduate students were recently awarded prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Awards (F31) from the National Cancer Institute of the National Institutes of Health (NIH).
- December 03, 2021
Chen Liu, MD, PhD, Chair of the Yale Department of Pathology, recently announced the 2021 Faculty Promotions. The 2021 promotion cycle included Natalia Buza, MD, Professor of Pathology, and Themis Kyriakides, PhD, Professor of Pathology, Paul Cohen, MD, Associate Professor of Pathology, Peter Gershkovich, MD, MHA, Associate Professor of Pathology, and Kurt Schalper, MD, PhD, Associate Professor of Pathology.
- November 24, 2021
Yale Cancer Center is home to a Specialized Programs of Research Excellence (SPORE) in Lung Cancer, which provides funding from the National Cancer Institute to translate research from Yale laboratories to our clinics. I actively participate in the Yale SPORE in Lung Cancer as the diagnostic pathologist on the team. Our current focus is on advancing targeted treatment options for lung cancer to benefit our patients using immunotherapy and molecular treatments.
- November 22, 2021
. I want our patients and families to know how dedicated we are to helping them using the tools we have now, but I also want them to understand that we are working tirelessly to find better answers for the future. I hope our patients can take comfort in knowing we are devoted to them.
- October 21, 2021
Eric P. Winer, MD, will be the next director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale New Haven, effective February 1, 2022.
- October 20, 2021
Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs
The National Institutes of Health has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center.
- October 20, 2021
A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity.
- October 13, 2021
Patients and their families need to be aware that although patients almost never meet the pathologist who read their report, as they work “behind the scenes,” pathologists work in close communication with clinical teams to define optimal treatment strategies tailored to each individual patient’s need.
- October 06, 2021
The National Cancer Institute has recognized Markus Müschen, MD, PhD, with its Outstanding Investigator Award.
- October 01, 2021
Margaret Gilshannon, MHA, has been appointed Deputy Director for Finance & Administration at Yale Cancer Center.